As our readers might know by now, Benzinga is constantly on the lookout for both good and bad investment options. One of our top sources for investments in the cannabis industry is Alan Brochstein, founding partner at New Cannabis Ventures and founder at 420 Investor, who periodically updates us on which marijuana stocks we should keep an eye on and which ones we should avoid.
In this occasion, the expert shared a look at two marijuana penny stocks with suspicious insider buys: mCig Inc MCIG and Players Network PNTV.
mCig’s Undisclosed Insider Sale
First off, Brochstein went into mCig. “This is a company that came out in 2013 and really disappointed people. It never really lived up to its promises,” he said.
Now, the company “is being heavily promoted,” he continued. “They are trying to build investor confidence— and so, one of the easy tools a company can use is have a — let’s call it — insider buy.”
So, this is what mCig did: Founder and CEO Paul Rosenberg recently disclosed the purchase of $100,000 of convertible preferred shares. However, there was something really weird about the transaction, Brochstein noted. The company had never properly disclosed a sale that Paul Rosenberg completed during the year ended April 30, 2016.
So, the investor looked into it and published an article explaining what was wrong with the filings. “I feel like this is a ploy by the company to build up confidence,” he said, talking about why he had written this piece.
“I just doesn't seem right that they would point attention to a purchase that becomes relatively small when compared to the sales that were made in the year ended April 2016. So, I demonstrated how they never accounted for — through a Form 4 or any other way — exactly how those millions of shares were disposed of, at what price, or anything like that,” he commented.
“That's the bottom line: I just feel like the company is playing a game here,” he ended.
Brochstein moved on to expound what is going on at another weed penny stock, Player’s Network.
“One of mCig's clients is Green Leaf Farms,” which is 80 percent owned by Players Network.
What’s interesting here is that Players Network is “playing the same game,” the expert noted. “The CEO made a video where he bragged about how he made this purchase— And, once again, there's no Form 4 on that one!” In fact, the last insider transaction disclosed by the company was completed in 2011.
Author’s Note: Player’s Netowork’s video was made by MoneyTV, which very recently made another video for Singlepoint Inc SING, one more cannabis-related company that has been subject of Brochstein’s inquiry due to its 'Slim And Shady' Finances – which might suggest a pump and dump.
The Common Theme
To sum up, Brochstein pointed out a common theme: “both companies are working together and out there kind of bragging about these insider purchases [...] I think both these companies are using a tactic to get investors involved by doing this.”
“Both these companies are obviously very promotional,” he added. “Player’s Network pays for MoneyTV and mCig is using MarijuanaStocks.com [which has been suspected of promoting stocks in the past] to promote its stock. So, they are both very promotional.”
While in mCig’s case, we are certain about the purchase happening, why are we not talking about the much larger sale that was never properly disclosed? — Brochstein wondered.
And, with Player's Network, it’s even worse, there’s no Form 4, he supplemented. “[The CEO] is out there saying he made a purchase and there's no evidence of this. And they said, 'we have filed a Form 4' [even though it is not on the SEC site]. So, something is not adding up.”
“It is probably a clerical mistake on their part,” the expert went on. “But still, that is very sloppy, to go out there and break the SEC's rules by not filing [a Form 4] within 48 hours [of the transaction]. It's probably just an oversight.”
“Both of these purchases have been widely publicized and come after big runs in the stock. It's not like these guys bought low; they are buying high and bragging about it,” Brochstein concluded.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.